Filter Releases
 
Press Releases
Date Title and Summary View
May 5, 2014
CAMBRIDGE, MA--(Marketwired - May 5, 2014) - Radius Health Announces Scientific Presentations at the 40th European Calcified Tissue Society (ECTS) Congress and at the joint meeting of the International Society of Endocrinology and the Endocrine Society (ICE/ENDO 2014)Radius Health, Inc. will present scientific data from studies conducte...
Jan 9, 2014
CAMBRIDGE, MA--(Marketwired - Jan 9, 2014) - Radius Health, Inc. ("Radius") announced today that it has strengthened its management team with the addition of John Yates, M.D., as Chief Medical Officer and Greg Williams, Ph.D., as Chief Development Officer, and the promotion of Gary Hattersley, Ph.D., to Chief Scientific Officer. ...
Jan 9, 2014
CAMBRIDGE, MA--(Marketwired - Jan 9, 2014) - Radius Health, Inc. ("Radius"), a late-stage biopharmaceutical company focused on developing novel therapeutics for osteoporosis and other serious endocrine-mediated diseases, today announced topline results from a Phase 2 study of BA058, or abaloparatide1, the company's novel synthetic pepti...
Dec 17, 2013
CAMBRIDGE, MA--(Marketwired - Dec 17, 2013) - Radius Health, Inc. ("Radius") announced today the appointment of Robert Ward as President and Chief Executive Officer. Mr. Ward takes on the role of CEO at a dynamic time when Radius is advancing its osteoporosis program in late-stage human clinical trials: The lead program, BA058-SC -- a potential...
Apr 25, 2013
CAMBRIDGE, MA--(Marketwired - Apr 25, 2013) -   Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health co...
Apr 18, 2013
CAMBRIDGE, MA--(Marketwired - Apr 18, 2013) -    Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's hea...
Mar 12, 2013
CAMBRIDGE, MA--(Marketwire - Mar 12, 2013) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the ...
Feb 26, 2013
CAMBRIDGE, MA--(Marketwire - Feb 26, 2013) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions, announced today that it will present at the 33rd annual Cowen & Company Health Care Conference. Michael Wyzga, Presi...
Feb 8, 2013
CAMBRIDGE, MA--(Marketwire - Feb 8, 2013) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions, a...
Jan 7, 2013
CAMBRIDGE, MA--(Marketwire - Jan 7, 2013) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions, is providing an update regarding the progress of its Phase 3 study of BA058-Subcutaneous (SC). BA0...
Jan 3, 2013
CAMBRIDGE, MA--(Marketwire - Jan 3, 2013) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions, completed enrollment for its randomized Phase 2 study of BA058-transdermal (BA058-TD) in healthy po...
Dec 20, 2012
Cambridge, Mass., December 20, 2012 – Radius Health, Inc. (“Radius”) and 3M Drug Delivery Systems are pleased to announce an exclusive partnership agreement for development and commercialization of BA058-transdermal (TD). BA058 is a novel, synthetic proprieta...
Nov 15, 2012
CAMBRIDGE, MA--(Marketwire - Nov 15, 2012) -  Radius Health, Inc. ("Radius"), announced today that it has voluntarily withdrawn its Registration Statement on Form S-1 (Registration No. 333-179397) (t...
Oct 12, 2012
CAMBRIDGE, MA--(Marketwire - Oct 12, 2012) - Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health...
Sep 27, 2012
Cambridge, MA, September 27, 2012 – Radius...
= add release to Briefcase